BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30621597)

  • 1. Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis.
    Liao H; Liu S; Wang H; Su H; Liu Z
    BMC Microbiol; 2019 Jan; 19(1):7. PubMed ID: 30621597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals.
    Paniágua AL; Correia AF; Pereira LC; de Alencar BM; Silva FBA; Almeida RM; de Medeiros Nóbrega YK
    BMC Complement Med Ther; 2021 Sep; 21(1):237. PubMed ID: 34556109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans.
    Liao H; Liu S; Wang H; Su H; Liu Z
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus acidophilus, L. plantarum, L. rhamnosus, and L. reuteri Cell-Free Supernatants Inhibit Candida parapsilosis Pathogenic Potential upon Infection of Vaginal Epithelial Cells Monolayer and in a Transwell Coculture System
    Spaggiari L; Sala A; Ardizzoni A; De Seta F; Singh DK; Gacser A; Blasi E; Pericolini E
    Microbiol Spectr; 2022 Jun; 10(3):e0269621. PubMed ID: 35499353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
    Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
    Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion.
    De Gregorio PR; Parolin C; Abruzzo A; Luppi B; Protti M; Mercolini L; Silva JA; Giordani B; Marangoni A; Nader-Macías MEF; Vitali B
    Microb Cell Fact; 2020 Jun; 19(1):133. PubMed ID: 32552788
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Cai X; Kong F; Wang R; Zhai S; Guan X; Zhang G; Wang D
    Future Microbiol; 2019 Jul; 14():839-846. PubMed ID: 31373210
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory effects of Lactobacillus rhamnosus and Lactobacillus casei on Candida biofilm of denture surface.
    Song YG; Lee SH
    Arch Oral Biol; 2017 Apr; 76():1-6. PubMed ID: 28063305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
    de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
    Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma-based strategy for inhibiting Candida albicans growth and CaMCA1 gene expression in vitro and reducing fungal pathogenicity in a murine model of vulvovaginal candidiasis.
    Ebrahimi-Shaghaghi F; Atyabi SM; Razzaghi-Abyaneh M
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34694384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F; Del Piano M; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract.
    Chen HL; Lai YW; Chen CS; Chu TW; Lin W; Yen CC; Lin MF; Tu MY; Chen CM
    Biometals; 2010 Jun; 23(3):543-54. PubMed ID: 20148305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of experimental murine vulvovaginal candidiasis with gentian violet.
    Bonfim AP; Sakita KM; Faria DR; Arita GS; Rodrigues-Vendramini FA; Capoci IR; Braga AG; Mosca VA; Junior AG; Kioshima ÉS; Bonfim-Mendonça PS; Svidzinski TI
    Future Microbiol; 2023 Nov; 18():1137-1146. PubMed ID: 37830930
    [No Abstract]   [Full Text] [Related]  

  • 18. Antifungal effect of hydroethanolic extract of Fridericia chica (Bonpl.) L. G. Lohmann leaves and its therapeutic use in a vulvovaginal candidosis model.
    Lima WG; Araújo MGF; Brito JCM; Castilho RO; Cardoso VN; Fernandes SOA
    J Mycol Med; 2022 Aug; 32(3):101255. PubMed ID: 35219909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The liquid Kangfuxin (KFX) has efficient antifungal activity and can be used in the treatment of vulvovaginal candidiasis in mice.
    Ma J; Yang YC; Su LQ; Qin DM; Yuan K; Zhang Y; Wang RR
    Lett Appl Microbiol; 2022 Apr; 74(4):564-576. PubMed ID: 34958703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis.
    Maraki S; Mavromanolaki VE; Stafylaki D; Nioti E; Hamilos G; Kasimati A
    Mycoses; 2019 Aug; 62(8):692-697. PubMed ID: 31132175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.